TY - JOUR
T1 - 18F-FDG and 68Ga-PSMA PET/CT in Paratesticular Mesothelioma
AU - Kalantari, F
AU - Schweighofer-Zwink, G
AU - Rendl, G
AU - Pirich, C
AU - Beheshti, M
N1 - alle: Division of Molecular Imaging and Theranostics, Department of Nuclear Medicine, University Hospital, Paracelsus Medical University, Salzburg, Austria
PY - 2024/4
Y1 - 2024/4
N2 - A 66-year-old man with local prostate adenocarcinoma underwent radical prostatectomy (Gleason score 3 + 4 = 7, pT2c) in 2016. Four years later, he presented with a hydrocele and cystic atypical change in the left scrotum and soft tissue in the left groin. Final histopathology revealed spermatic cord mesothelioma and left hemangiosis carcinomatosa. A bone biopsy of the sacrum revealed infiltrates of a prostatic adenocarcinoma with small cell neuroendocrine differentiation. Dual-tracer PET/CT imaging using F-18-FDG and Ga-68-PSMA was able to identify local recurrence of scrotal mesothelioma and differentiate metastases of prostate cancer from malignant mesothelioma.
AB - A 66-year-old man with local prostate adenocarcinoma underwent radical prostatectomy (Gleason score 3 + 4 = 7, pT2c) in 2016. Four years later, he presented with a hydrocele and cystic atypical change in the left scrotum and soft tissue in the left groin. Final histopathology revealed spermatic cord mesothelioma and left hemangiosis carcinomatosa. A bone biopsy of the sacrum revealed infiltrates of a prostatic adenocarcinoma with small cell neuroendocrine differentiation. Dual-tracer PET/CT imaging using F-18-FDG and Ga-68-PSMA was able to identify local recurrence of scrotal mesothelioma and differentiate metastases of prostate cancer from malignant mesothelioma.
KW - Neuroendocrine differentiation
KW - Paratesticular mesothelioma
KW - Prostate cancer
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pmu_pure&SrcAuth=WosAPI&KeyUT=WOS:001179554700039&DestLinkType=FullRecord&DestApp=WOS_CPL
U2 - 10.1097/RLU.0000000000005123
DO - 10.1097/RLU.0000000000005123
M3 - Case report
C2 - 38427957
SN - 0363-9762
VL - 49
SP - 332
EP - 332
JO - CLINICAL NUCLEAR MEDICINE
JF - CLINICAL NUCLEAR MEDICINE
IS - 4
ER -